IRYCIS
miRNA 127 agents for use in the treatment of renal fibrosis
Biomarkers / Diagnostic
Kidney and Genitourinary system
A method of prophylactically or therapeutically treating Chronic kidney disease (CKD) or of reducing the risk of CKD disease progression in a patient comprising expressing miR-127 in the renal cells
3Clinical validation,
2Preclinical Validation,
1R+D
Spain